Otherside Farms
JANUARY 25, 2019
Norman Smith: “Since I am the only successful patient in the clinical trial, to take away something that’s been part of a successful regimen does not make any sense” In September 2010, Smith became eligible for a liver transplant, but after testing positive for marijuana in February he was removed from the transplant list.
Cannabis Law Report
JULY 25, 2022
Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. He is an outspoken commentator on Climate Change and Security using community advocacy to raise awareness of the potential costs of inaction.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
SMPL
MAY 26, 2020
Mr. Gardner, the writer whose CBD advocacy eventually inspired the 2011 summit at Ms. DeAngelo, who had been in contact with Mr. Gardner about the urgent need to institute better testing, agreed to help fund a cannabis analysis lab, Steep Hill, which began its operations in 2008. But the research wasn’t enough.
Cannabis Law Report
NOVEMBER 24, 2021
2018 ; Frankhauser 2008 ). 2008 )—were difficult for any plant to compete with, especially one whose active constituents would not be revealed for another 30?years It also has an extensive and diverse history of medicinal use. 2016 ; Sznitman et al. years (Atakan 2012 ). Complexity of prescribing and patient access (n?=?25).
Cannabis Law Report
JUNE 4, 2021
Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Healing Advocacy Fund. In 2008 Peter joined Teva, a generic drug giant, to work directly with pharmaceutical formulation teams.
Expert insights. Personalized for you.
76 
Let's personalize your content